Skip to main content

JPMORGAN CHASE & CO

Position in NVCT — Nuvectis Pharma, Inc.

CIK 19617 NEW YORK, NY

Position in NVCT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$50,027
+$1,844 QoQ
Shares Held
6,472
+1.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 3% Shared 0% None 97%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. NVCT ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $50,027 6,472
2025-12-31 $48,183 6,382
2025-09-30 $32,007 5,317
2025-06-30 $46,784 6,263
2025-03-31 $1,748 179
2024-12-31 $968 179
2024-09-30 $1,206 192
2024-06-30 $93,386 14,753
2024-03-31 $42,352 5,165
2023-12-31 $40,882 4,902
2023-09-30 $63,186 4,902
2023-06-30 $87,196 5,460